Literature DB >> 24396676

The expression of tumor-associated macrophages in papillary thyroid carcinoma.

Bo Hyun Kim1.   

Abstract

Entities:  

Year:  2013        PMID： 24396676      PMCID： PMC3811693          DOI： 10.3803/EnM.2013.28.3.178

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN： 2093-596X


× No keyword cloud information.
  13 in total

1.  Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.

Authors:  Shinichi Tsutsui; Kazuhiro Yasuda; Kosuke Suzuki; Kouichirou Tahara; Hidefumi Higashi; Shoichi Era
Journal:  Oncol Rep       Date:  2005-08       Impact factor: 3.906

2.  In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.

Authors:  A Fiumara; A Belfiore; G Russo; E Salomone; G M Santonocito; O Ippolito; R Vigneri; P Gangemi
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

Review 3.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

4.  Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Wei Qing; Wei-Yuan Fang; Lei Ye; Li-Yun Shen; Xiao-Fang Zhang; Xiao-Chun Fei; Xi Chen; Wei-Qing Wang; Xiao-Ying Li; Jia-Cheng Xiao; Guang Ning
Journal:  Thyroid       Date:  2012-08-07       Impact factor: 6.568

5.  Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.

Authors:  Shunki Hirayama; Genichiro Ishii; Kanji Nagai; Shotaro Ono; Motohiro Kojima; Chisako Yamauchi; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Kenji Suzuki; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.

Authors:  Mabel Ryder; Ronald A Ghossein; Julio C M Ricarte-Filho; Jeffrey A Knauf; James A Fagin
Journal:  Endocr Relat Cancer       Date:  2008-08-21       Impact factor: 5.678

Review 8.  Identification and manipulation of tumor associated macrophages in human cancers.

Authors:  Moniek Heusinkveld; Sjoerd H van der Burg
Journal:  J Transl Med       Date:  2011-12-16       Impact factor: 5.531

9.  The expression of tumor-associated macrophages in papillary thyroid carcinoma.

Authors:  Seunghwan Kim; Sun Wook Cho; Hye Sook Min; Kang Min Kim; Gye Jeong Yeom; Eun Young Kim; Kyu Eun Lee; Yeo Gyu Yun; Do Joon Park; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09-13

Review 10.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996
View more
  4 in total

1.  Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.

Authors:  Kensey Bergdorf; Donna C Ferguson; Mitra Mehrad; Kim Ely; Thomas Stricker; Vivian L Weiss
Journal:  Endocr Relat Cancer       Date:  2019-06       Impact factor: 5.678

2.  GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.

Authors:  Mengyuan Li; Hongwei Jiang; Shengjiang Chen; Yujin Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Xing-Wei Xie; Shan-Shan Jiang; Xiang Li
Journal:  Front Mol Biosci       Date:  2021-01-20

4.  Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer.

Authors:  Wenlong Wang; Ning Bai; Xinying Li
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.